Vectalys will attend the AACR Annual Meeting in Washington DC, April 1-5, 2017.
Vectalys attended the CRISPR congress Berlin 2016 to present an innovative RNA delivery particle named LentiFlash. This particle is based on a new chimeric bacteriophage-based lentiviral platform a...
We look forward to sharing with you the results of our new non-integrative MS2-based lentiviral particles for RNA delivery during the upcoming CRISPR congress Europe in Berlin.
We are pleased to announce our 0,9M€ fundraising. Vectalys has raised funds for its development. See our press release here (In french).
Vectalys will attend the ASGCT on May 4-7, 2016 in Washington, DC to introduce the next generation of non integrating lentiviral particle for gene and cell therapy applications.
Vectalys is pleased to announce the launch of its brand new website. We wanted to make this website faster, easier to navigate and with content tailored to all level of expertise in lentiviral vect...